Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-20
DOI
10.1038/s41380-019-0400-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Editorial Board Page
- (2018) BIOLOGICAL PSYCHIATRY
- Common Neurotransmission Recruited in ( R , S )-Ketamine and (2 R ,6 R )-Hydroxynorketamine–Induced Sustained Antidepressant-like Effects
- (2018) Thu Ha Pham et al. BIOLOGICAL PSYCHIATRY
- AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite ( S )-Norketamine
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
- (2018) Jennifer W. Evans et al. BIOLOGICAL PSYCHIATRY
- Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine
- (2018) Sriparna Ghosal et al. BIOLOGICAL PSYCHIATRY
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
- (2018) Chadi G. Abdallah et al. PHARMACOLOGY & THERAPEUTICS
- Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
- (2018) Allie J. Widman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-Term Stress Disrupts the Structural and Functional Integrity of GABAergic Neuronal Networks in the Medial Prefrontal Cortex of Rats
- (2018) Boldizsár Czéh et al. Frontiers in Cellular Neuroscience
- Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging
- (2018) Ming-Kai Chen et al. JAMA Neurology
- Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder
- (2018) Lawrence Park et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
- (2018) Yan Yang et al. NATURE
- Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model
- (2018) Kai Zhang et al. PSYCHOPHARMACOLOGY
- Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
- (2017) Kenichi Fukumoto et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
- (2017) Yukihiko Shirayama et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
- (2017) Stephen Kanes et al. LANCET
- Dopamine D1 receptor subtype mediates acute stress-induced dendritic growth in excitatory neurons of the medial prefrontal cortex and contributes to suppression of stress susceptibility in mice
- (2017) R Shinohara et al. MOLECULAR PSYCHIATRY
- Effects of a ketamine metabolite on synaptic NMDAR function
- (2017) Kanzo Suzuki et al. NATURE
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders
- (2017) David Mataix-Cols et al. JAMA Psychiatry
- The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant
- (2016) Joseph Moskal et al. Current Neuropharmacology
- Activity-dependent signaling: influence on plasticity in circuits controlling fear-related behavior
- (2016) Julia L Hill et al. CURRENT OPINION IN NEUROBIOLOGY
- Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state
- (2016) T Fuchs et al. MOLECULAR PSYCHIATRY
- Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation
- (2016) M M Harraz et al. MOLECULAR PSYCHIATRY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
- (2016) Ronald S Duman et al. NATURE MEDICINE
- Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures
- (2016) Ashley E. Lepack et al. NEUROPHARMACOLOGY
- Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition
- (2016) Oliver H. Miller et al. NEUROPHARMACOLOGY
- Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study
- (2016) Gerard Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine Treatment and Global Brain Connectivity in Major Depression
- (2016) Chadi G Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine
- (2016) Rong-Jian Liu et al. NEUROPSYCHOPHARMACOLOGY
- Sex-Dependent Anti-Stress Effect of an α5 Subunit Containing GABAA Receptor Positive Allosteric Modulator
- (2016) Sean C. Piantadosi et al. Frontiers in Pharmacology
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents
- (2015) Julie L. Engers et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism
- (2015) K. M. Huber et al. JOURNAL OF NEUROSCIENCE
- Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent
- (2015) SHELDON PRESKORN et al. Journal of Psychiatric Practice
- Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway
- (2015) Francis L. Pazini et al. MOLECULAR NEUROBIOLOGY
- Activation of a ventral hippocampus–medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine
- (2015) F R Carreno et al. MOLECULAR PSYCHIATRY
- Transcriptome changes induced by chronic psychosocial/environmental or neuroendocrine stressors reveal a selective cellular vulnerability of cortical somatostatin (SST) neurons, compared with pyramidal (PYR) neurons
- (2015) L C Lin et al. MOLECULAR PSYCHIATRY
- Nutrient-sensing mechanisms and pathways
- (2015) Alejo Efeyan et al. NATURE
- Stress weakens prefrontal networks: molecular insults to higher cognition
- (2015) Amy F T Arnsten NATURE NEUROSCIENCE
- Mechanisms of stress in the brain
- (2015) Bruce S McEwen et al. NATURE NEUROSCIENCE
- Dysregulation and restoration of translational homeostasis in fragile X syndrome
- (2015) Joel D. Richter et al. NATURE REVIEWS NEUROSCIENCE
- The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN
- (2015) Kenichi Fukumoto et al. NEUROPSYCHOPHARMACOLOGY
- Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors
- (2015) Jonathan Fischell et al. NEUROPSYCHOPHARMACOLOGY
- The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus
- (2015) J. Burgdorf et al. NEUROSCIENCE
- Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions
- (2015) Manabu Fuchikami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
- (2014) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors
- (2014) Daniela da Fonseca Pacheco et al. BRAIN RESEARCH
- The role of reproductive hormones in postpartum depression
- (2014) Crystal Edler Schiller et al. CNS SPECTRUMS
- Cortical GABA neurons and self-focus in depression: a model linking cellular, biochemical and neural network findings
- (2014) G Northoff et al. MOLECULAR PSYCHIATRY
- Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
- (2014) Laura Pozzi et al. PLoS One
- Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test
- (2014) Kenichi Fukumoto et al. PSYCHOPHARMACOLOGY
- GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine
- (2014) Oliver H Miller et al. eLife
- Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses
- (2013) Bhavya Voleti et al. BIOLOGICAL PSYCHIATRY
- Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression
- (2013) Chih-Chia Huang et al. BIOLOGICAL PSYCHIATRY
- Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
- (2013) John H. Krystal et al. BIOLOGICAL PSYCHIATRY
- Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
- (2013) W. Zhou et al. EUROPEAN PSYCHIATRY
- The State of US Health, 1990-2010
- (2013) Christopher J. L. Murray JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans
- (2013) N R Driesen et al. MOLECULAR PSYCHIATRY
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
- (2013) G Sanacora et al. MOLECULAR PSYCHIATRY
- The Brain on Stress: Vulnerability and Plasticity of the Prefrontal Cortex over the Life Course
- (2013) Bruce S. McEwen et al. NEURON
- Sex differences in the antidepressant-like effects of ketamine
- (2013) Nicole Carrier et al. NEUROPHARMACOLOGY
- Form follows function: BDNF and its involvement in sculpting the function and structure of synapses
- (2013) Marta Zagrebelsky et al. NEUROPHARMACOLOGY
- GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
- (2013) Jeffrey Burgdorf et al. NEUROPSYCHOPHARMACOLOGY
- Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
- (2012) Gonzalo Laje et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- A randomized add-on trial of high-dose d-cycloserine for treatment-resistant depression
- (2012) Uriel Heresco-Levy et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers
- (2012) S. De Simoni et al. NEUROIMAGE
- Neurosteroids, stress and depression: Potential therapeutic opportunities
- (2012) Charles F. Zorumski et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Capturing the Angel in "Angel Dust": Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans
- (2012) B. Moghaddam et al. SCHIZOPHRENIA BULLETIN
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
- (2011) Rong-Jian Liu et al. BIOLOGICAL PSYCHIATRY
- mTOR activation is required for the antidepressant effects of mGluR2/3 blockade
- (2011) Jason M. Dwyer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Acute d-serine treatment produces antidepressant-like effects in rodents
- (2011) Oz Malkesman et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- A Critical Role for GluN2B-Containing NMDA Receptors in Cortical Development and Function
- (2011) Chih-Chieh Wang et al. NEURON
- Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists
- (2011) Hiroyuki Koike et al. NEUROPHARMACOLOGY
- New advances in NMDA receptor pharmacology
- (2011) Kevin K. Ogden et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial
- (2010) Wayne C. Drevets et al. BIOLOGICAL PSYCHIATRY
- Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex
- (2010) Erin R. Hascup et al. JOURNAL OF NEUROCHEMISTRY
- The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?
- (2010) G MacQueen et al. MOLECULAR PSYCHIATRY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- mTOR signaling: At the crossroads of plasticity, memory and disease
- (2009) Charles A. Hoeffer et al. TRENDS IN NEUROSCIENCES
- Glutamate and the Neural Basis of the Subjective Effects of Ketamine
- (2008) J. F. William Deakin et al. ARCHIVES OF GENERAL PSYCHIATRY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: Role of corticosterone-mediated apical dendritic atrophy
- (2008) R.-J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search